The results of a retrospective analysis of 467 patients with STEMI without cardiogenic shock and pulmonary edema. It was found that the initially mildly and moderately reduced level of glomerular filtration rate (45-89 ml/min/1,73m2) does not affect the long-term prognosis of patients, but worsening of renal function (20% or more) within 7 days of hospital stay was associated with a more than two fold increase in the incidence of cardiovascular death and combination of cardiovascular death and recurrent myocardial infarction during the next 3 years of follow up. History of hypertension, diabetes and heart failure affected renal function on the 1st day of myocardial infarction, but were not associated with worsening renal function after 7 days of hospital stay. Links between a violation of intracardiac and central hemodynamics, as well as the use of X-ray contrast media and glomerular filtration rate reduction has not been established.
посібник НАМН України. — К., 2012. — 211 с.
2. Arici M., Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Іs C-reactive protein the missing link? // Kidney Int. — 2001. — 59 (2). — Р. 407-414.
3. Culleton B.F., Larson M.G., Wilson P.W. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency // Kidney Int. — 1999. —
56 (6). — Р. 2214-2219.
4. KDIGO 2012 Clinical practice guideline for the evaluation and management of Chronic Kidney Disease // Kidney Int. — 2013. — 3 (1). — Р. 1-150.
5. Gitt A.K., Zahn R., Zeymer U. Risk-treatment-paradox and high mortality in STEMI with impaired renal function in clinical practice in Europe: Lessons from the Euro Heart Survey ACS Registry // J. Am. Coll. Cardiol. — 2010. — Vol. 55, Issue 10A.
6. Goldenberg I., Subirana I., Boyko V. et al. Relation between renal function and outcomes in patients with non-STsegment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project // Arch. Intern. Med. — 2010. — 170 (10). — P. 888-895.
7. Hillege H.L., van Gilst W.H., van Veldhuisen D.J. et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits
of ACE inhibition: the CATS randomized trial // Eur. Heart J. — 2003. — 24 (5). — P. 412-420.
8. Lee S.H., Kim Y.J., Kim W. et al. Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the
Korean Acute Myocardial Infarction Registry // Circ. J. — 2008. — 72 (9). — P. 1410-1418.
9. Levey A.S., Bosch J.P., Lewis J.B. et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group // Ann. Intern. Med. — 1999. — 130 (6). — P. 461-470.
10. Miyata T., Maeda K., Kurokawa K., van Ypersele de Strihou C. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure // Nephrol. Dial. Transplant. — 1997. — 12 (2). — P. 255-258.
11. Rossignol P., Cleland J.G., Bhandari S. et al. Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study // Circulation. — 2012. — 125 (2). — P. 271-279.
12. Santopinto J.J., Fox K.A., Goldberg RJ. et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE) // Heart. — 2003. — 89. — P. 1003-1008.